Support WBURFDA Faulted For Lapses In Orphan Drug ProgramSydney LupkinNovember 30, 2018 ShareThe Food and Drug Administration has seen a sharp increase in applications for drug to treat rare diseases. An oversight report found problems with how agency is handling them. (Al Drago/CQ Roll Call/Getty Images)
